Annals of Allergy Asthma & Immunology

Article	Citations
Atopic dermatitis in the pediatric population	234
New treatments in atopic dermatitis	136
The infectious complications of atopic dermatitis	96
Asthma and the social determinants of health	91
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma	75
Anaphylaxis: A 2023 practice parameter update	63
Potential association of mast cells with coronavirus disease 2019	60
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis	57
The COVID-19 pandemic	57
New and emerging treatments for inflammatory itch	53
Social media and its impact on health care	52
Secondary immunodeficiencies	50
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis	49
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Ins	47
Hereditary alpha-tryptasemia in 101 patients with mast cell activation–related symptomatology including anaphylaxis	47
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection	44
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions	44
Real-world persistence with dupilumab among adults with atopic dermatitis	43
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions	39
Biologics in eosinophilic gastrointestinal diseases	38
Clinical guidance for the use of dupilumab in eosinophilic esophagitis	37
A review of contact dermatitis	37
Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY	37
Assessment and feedback methods in competency-based medical education	36
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in	35

Diagnostic testing for galactose-alpha-1,3-galactose, United States, 2010 to 2018	35
Bleach baths for atopic dermatitis	34
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines	34
Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use	34
Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019	33
Prenatal PM2.5 exposure and vitamin D–associated early persistent atopic dermatitis via placental methylation	33
Food protein-induced enterocolitis syndrome epidemiology	33
A scoping review of the caregiver burden of pediatric food allergy	32
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma	32
Clinical relevance of inherited genetic differences in human tryptases	32
Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin	32
Breaking down the complex pathophysiology of eosinophilic esophagitis	30
The origins of allergy from a systems approach	30
One march, many paths: Insights into allergic march trajectories	29
High anxiety and health-related quality of life in families with children with food allergy during coronavirus disease 2019	29
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy	28
Oral Janus kinase inhibitors for atopic dermatitis	28
Clinical and economic burden of severe asthma among US patients treated with biologic therapies	28
Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency	28
Food allergy-related bullying and associated peer dynamics among Black and White children in the FORWARD study	27
Traditional Chinese medicine for food allergy and eczema	27
Inherited and acquired determinants of serum tryptase levels in humans	27
The epidemiology of multifood allergy in the United States	27
A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency	26
Asthma in patients with coronavirus disease 2019	26
Evaluating the impact of coronavirus disease 2019 on asthma morbidity	26
Current medical management of hereditary angioedema	26
Food protein-induced enterocolitis syndrome oral food challenge	25
Early, continuing exposure to cow's milk formula and cow's milk allergy	25
Incidence of and risk factors for perioperative or periprocedural anaphylaxis in the United States from 2005 to 2014	25
Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy	25
Advances in understanding immune mechanisms of food protein–induced enterocolitis syndrome	24
Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study	24
Association of itch triggers with atopic dermatitis severity and course in adults	24
Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule	24
Optimizing emollient therapy for skin barrier repair in atopic dermatitis	24
Clinical phenotyping of atopic dermatitis using combined itch and lesional severity	23
Food insecurity in children and adults with food allergies	23
Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease	23
Group 2 innate lymphoid cells in nasal polyposis	23
Childhood atopic dermatitis is associated with cognitive dysfunction	23
The epidemiology of food allergy in adults	23
Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients	23
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities	23
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic	22
Health disparities in pediatric food allergy	22
Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy	22
State-of-the-art diagnostic evaluation of common variable immunodeficiency	22
Atopic dermatitis and dementia risk	22
Future of allergic rhinitis management	22

Vitamin D and iron status in children with food allergy	21
Outside-in hypothesis revisited	21
Association between cognitive function and asthma in adults	21
Strategies for choosing a biologic for your patient with allergy or asthma	20
Rhinitis prevalence and association with atopic dermatitis	20
Optimizing topical management of atopic dermatitis	20
Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis	20
Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination	20
Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly	20
Severe asthma exacerbations in the United States:	20
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines	20
Immunizing the imperfect immune system	20
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics	19
Tick bite as a risk factor for alpha-gal–specific immunoglobulin E antibodies and development of alpha-gal syndrome	19
Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy	19
Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease	19
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019	18
Parents of children with food allergy	18
Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States	18
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis	18
Long-term pollen trends and associations between pollen phenology and seasonal climate in Atlanta, Georgia (1992-2018)	18
Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma	18
A butterfly flaps its wings	18
Developing and evaluating ASTHMAXcel adventures	18
Local immunoglobulin production in nasal tissues	18
Medication adherence in Medicare-enrolled older adults with asthma before and during the coronavirus disease 2019 pandemic	18
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps	18
Update on indoor allergens and their impact on pediatric asthma	17
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy	17
Socioeconomic determinants of food allergy burden	17
The association between duration of breastfeeding and childhood asthma outcomes	17
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety	17
Cow’s milk allergy prevention	17
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia	17
Testosterone-to-estradiol ratio and lung function in a prospective study of Puerto Rican youth	16
Insights into allergic risk factors from birth cohort studies	16
Chronic adult food protein–induced enterocolitis syndrome	16
Evidence-based use of antihistamines for treatment of allergic conditions	16
The impact of levels of particulate matter with an aerodynamic diameter smaller than 2.5 μm on the nasal microbiota in chronic rhinosinusitis and healthy individuals	16
Tuft cells in the pathogenesis of chronic rhinosinusitis with nasal polyps and asthma	16
Real-world efficacy and safety of dupilumab use in the treatment of asthma	16
Detection of neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines	16
The practical dietary management of food protein-induced enterocolitis syndrome	16
Immune-related cutaneous adverse events due to checkpoint inhibitors	16
A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice	16
Corticosteroid exposure and cumulative effects in patients with eczema	16
Asthma in patients with suspected and diagnosed coronavirus disease 2019	16
Atopic Dermatitis Yardstick update	16
Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis	15
Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march	15
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough	15
Predictors of nonresponse to dupilumab in patients with atopic dermatitis	15
Asthma biologics	15
The shifting prevalence of asthma and allergic disease in US children	15
Single-step direct drug provocation testing is safe for delabelling selected non–low-risk penicillin allergy labels	15
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273	14
T2-low: what do we know?	14
Further evidence for association of YKL-40 with severe asthma airway remodeling	14
Yardstick for the medical management of chronic rhinosinusitis	14
Should we apply a treatable traits approach to asthma care?	14
Understanding the role of long-acting muscarinic antagonists in asthma treatment	14
Social determinants of health and primary immunodeficiency	14
Tryptase in type I hypersensitivity	14
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later	14
Better maternal quality of life in pregnancy yields better offspring respiratory outcomes	14
The evolution of food protein–induced enterocolitis syndrome	14
Outcomes for clinical trials of food allergy treatments	14
Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine	14
Interleukin-6 and cytokine release syndrome	14
Differences in oral food challenge reaction severity based on increasing age in a pediatric population	14
Serum-free immunoglobulin E	13
YouTube as a source of (mis)information on allergic rhinitis	13
Innovations in the treatment of anaphylaxis: A review of recent data	13
Quality of life in patients with hereditary angioedema in Canada	13
On the surface	13
Safety and outcomes of penicillin allergy evaluation in pregnant women	13
Asthma interactions between obesity and other risk factors	13
Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy	13
Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions	13
Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens	13

Use of omalizumab for management of idiopathic anaphylaxis	13
Penicillin allergy delabeling	13
Moisturizer therapy in prevention of atopic dermatitis and food allergy: To use or disuse?	13
The use of microarray and other multiplex technologies in the diagnosis of allergy	13
Inverse associations between food diversity in the second year of life and allergic diseases	13
Food protein–induced enterocolitis syndrome	13
Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network	13
A review of cannabis allergy in the early days of legalization	13
Filaggrin and beyond	13
Skin testing as a biomarker in drug allergy	13
Update on allergic fungal rhinosinusitis	13
Comorbid posttraumatic stress disorder and major depressive disorder are associated with asthma morbidity among World Trade Center workers	13
Trends in US hospitalizations for anaphylaxis among infants and toddlers	13
Allergy and Immunology Physician Workforce	13
Does allergen immunotherapy for allergic rhinitis prevent asthma?	13
Treatment of food allergy	13
Comorbidities in childhood-onset and adult-onset asthma	12
Inhaled corticosteroids for the prevention of asthma exacerbations	12
Omalizumab response in patients with asthma by number and type of allergen	12
Mapping geographic variability of severe uncontrolled asthma in the United States	12
Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy	12
Characteristics of patients with spontaneous resolution of sesame allergy	12
The spectrum of allergic ocular diseases	12
Food protein-induced enterocolitis syndrome to nuts	12
Cognitive-behavioral intervention for anxiety associated with food allergy in a clinical sample of children	12
Military burn pit exposure and airway disease	12
Steroid-induced secondary immune deficiency	12
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)	12
Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor–monoclonal antibodies and desensitization	12
Intrabreath oscillometry is a sensitive test for assessing disease control in adults with severe asthma	12
The impact of temperature on the skin barrier and atopic dermatitis	12
Clinical impact of obesity on oscillometry lung mechanics in adults with asthma	11
Management of acute food protein-induced enterocolitis syndrome emergencies at home and in a medical facility	11
Physician well-being in allergy and immunology	11
Predictors and biomarkers of food allergy and sensitization in early childhood	11
Delabeling penicillin allergy in a pediatric primary care clinic	11
Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab	11
Maternal obesity, gestational weight gain, and offspring asthma and atopy	11
Dupilumab as a novel therapy to treat adrenergic urticaria	11
Food protein–induced enterocolitis syndrome	11
Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab	11
Serum insulin-like growth factor-1, asthma, and lung function among British adults	11
Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma	11
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis	11
Development of IMPAACT (Impairment Measure for Parental Food Allergy-Associated Anxiety and Coping Tool), a validated tool to screen for food allergy-associated parental anxiety	11
Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma	11
Gastrointestinal immunopathology of food protein–induced enterocolitis syndrome and other non-immunoglobulin E–mediated food allergic diseases	11
Lymphocyte transformation test for drug allergy detection	11
Real-world evidence	11
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada	10
Social and financial impacts of food allergy on the economically disadvantaged and advantaged families	10
Sex effects in the association between airway microbiome and asthma	10
Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration	10
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study	10
Biologic use and outcomes among adults with severe asthma treated by US subspecialists	10
Impulse oscillometry and free-running tests for diagnosing asthma and monitoring lung function in young children	10
Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy	10
The evolution of allergy immunotherapy	10
Efficacy of biologic therapy on airway hyperresponsiveness in asthma	10
Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity	10
Quality of life is lower in adults labeled with childhood-onset food allergy than in those with adult-onset food allergy	10
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review	10
Antihistamine premedication improves safety and efficacy of allergen immunotherapy	10
Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation	10
Noninvasive tests for eosinophilic esophagitis: Ready for use?	10
Coconut allergy	10
Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps	10
Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol	10
Exhaled nitric oxide measurements are not influenced by anti-eosinophil therapy in patients with asthma	10
Current state of biologics in treating eosinophilic esophagitis	10
Food protein–induced allergic proctocolitis may have distinct phenotypes	10
Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis	10
Intimate partner violence and asthma in pediatric and adult populations	10
Perceived stress links income loss and urticaria activity during the coronavirus disease 2019 pandemic	10
The adverse reactions to vaccines practice parameter 10 years on—what have we learned?	9
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma	9
Race and ethnicity define disparate clinical outcomes in chronic rhinosinusitis	9
Emerging concepts in neuropathic and neurogenic itch	9
Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease	9
A comparison of the effectiveness of biologic therapies for asthma	9
Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis	9
Coping, social support, and anxiety in people with mast cell disorders	9
Anti–immunoglobulin E for food allergy	9
A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA)	9
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis	9
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall	9
Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules	9
Treatment approaches for the patient with T2 low asthma	9
Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination	9
Spontaneous sputum discriminates inflammatory phenotypes in patients with asthma	9
Extracellular vesicle-derived microbiome obtained from exhaled breath condensate in patients with asthma	9
Reimbursement patterns and user experiences in pediatric allergy home telehealth	9
Allergic disease, sleep problems, and psychological distress in children recruited from the general community	9
Performance of a computable phenotype for pediatric asthma using the problem list	9
Factors by which global warming worsens allergic disease	9